The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/11709
StudyName: Eligibility ATLAS ACS TIMI 46 Acute Coronary Syndrome NCT00402597
Date of export from the portal: 02.07.2020
Date of Upload / last change: 28.07.2015
License: Creative Commons BY 4.0

----

Description: 
The purpose of this study is to evaluate the safety of rivaroxaban in patients with recent acute coronary syndrome (ACS) and to assess the ability of rivaroxaban to reduce the occurrence of death, myocardial infarction (heart attack), repeat myocardial infarctions, stroke, and ischemia (inadequate blood supply to a local area) in patients with recent ACS.

https://clinicaltrials.gov/ct2/show/NCT00402597
